The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis

被引：0
|
作者：
Fa Mee Doh
Tae-Ik Chang
Hyang Mo Koo
Mi Jung Lee
Dong Ho Shin
Chan Ho Kim
Kwang Il Ko
Hyung Jung Oh
Tae-Hyun Yoo
Shin-Wook Kang
Dae-Suk Han
Seung Hyeok Han
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] NHIC Ilsan Hospital,Division of Nephrology
[3] Yonsei University,Brain Korea 21 for Medical Science, Severance Biomedical Science Institute
来源：
Cardiovascular Drugs and Therapy | 2012年 / 26卷
关键词：
HMG-CoA reductase inhibitor; Insulin resistance; Peritoneal dialysis; Adipokine; Chronic inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 509
页数：8
相关论文
共 50 条
  • [21] HEPATIC AND NONHEPATIC STEROL SYNTHESIS AND TISSUE DISTRIBUTION FOLLOWING ADMINISTRATION OF A LIVER SELECTIVE HMG-COA REDUCTASE INHIBITOR, CI-981 - COMPARISON WITH SELECTED HMG-COA REDUCTASE INHIBITORS
    BOCAN, TMA
    FERGUSON, E
    MCNALLY, W
    UHLENDORF, PD
    MUELLER, SB
    DEHART, P
    SLISKOVIC, DR
    ROTH, BD
    KRAUSE, BR
    NEWTON, RS
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1123 (02) : 133 - 144
  • [22] The HMG-CoA reductase inhibitor cerivastatin lowers advanced glycation end products in patients with type 2 diabetes
    Scharnagl, H.
    Stojakovic, T.
    Winkler, K.
    Rosinger, S.
    Maerz, W.
    Boehm, B. O.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (06) : 372 - 375
  • [23] Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia
    Kumai, T
    Oonuma, S
    Matsumoto, N
    Takeba, Y
    Taniguchi, R
    Kamio, K
    Miyazu, O
    Koitabashi, Y
    Sekine, S
    Tadokoro, M
    Kobayashi, S
    LIFE SCIENCES, 2004, 74 (17) : 2129 - 2142
  • [24] In vitro and in vivo antiproliferative effects of simvastatin, an HMG-CoA reductase inhibitor, on human glioma cells
    Kikuchi, T
    Nagata, Y
    Abe, T
    JOURNAL OF NEURO-ONCOLOGY, 1997, 34 (03) : 233 - 239
  • [25] An in vitro study of the hydroxyl radical scavenging-property of fluvastatin, an HMG-CoA reductase inhibitor
    Suzumura, K
    Yasuhara, M
    Tanaka, K
    Odawara, A
    Narita, H
    Suzuki, T
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1999, 47 (07) : 1010 - 1012
  • [26] In vitro and in vivo antiproliferative effects of simvastatin, an HMG-CoA reductase inhibitor, on human glioma cells
    Tetsuro Kikuchi
    Yasufumi Nagata
    Toshiaki Abe
    Journal of Neuro-Oncology, 1997, 34 : 233 - 239
  • [27] Synthesis of γ,γ-difluoro-β-hydroxy-δ-lactones as new precursors of HMG-CoA reductase inhibitor
    Wang, Xiaoguang
    Fang, Xiang
    Xiao, Hongyuan
    Yin, Yan
    Xia, Huimin
    Wu, Fanhong
    JOURNAL OF FLUORINE CHEMISTRY, 2012, 133 : 178 - 183
  • [28] Functional Implications of HMG-CoA Reductase Inhibition on Glucose Metabolism
    Han, Ki Hoon
    KOREAN CIRCULATION JOURNAL, 2018, 48 (11) : 951 - 963
  • [29] Isolation of HMG-CoA reductase inhibitors from aronia juice
    Kozuka, Miyuki
    Yamane, Takuya
    Imai, Momoko
    Handa, Satoshi
    Takenaka, Shigeo
    Sakamoto, Tatsuji
    Ishida, Tetsuo
    Inui, Hiroshi
    Yamamoto, Yoshio
    Nakagaki, Takenori
    Nakano, Yoshihisa
    FOOD BIOSCIENCE, 2020, 34
  • [30] BILE-ACID DERIVED HMG-COA REDUCTASE INHIBITORS
    KRAMER, W
    WESS, G
    ENHSEN, A
    BOCK, K
    FALK, E
    HOFFMANN, A
    NECKERMANN, G
    GANTZ, D
    SCHULZ, S
    NICKAU, L
    PETZINGER, E
    TURLEY, S
    DIETSCHY, JM
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1994, 1227 (03): : 137 - 154
12345